VivoSim Labs (VIVS) EBIT (2010 - 2026)

VivoSim Labs has reported EBIT for 17 years, with the latest figure at -$2.8 million in Q2 2026.

• On a quarterly basis, EBIT rose 5.35% year-over-year to -$2.8 million in Q2 2026; TTM through Jun 2026 was -$11.3 million, a 6.7% increase from a year earlier, with the FY2026 full-year figure at -$11.5 million, up 8.95% from the prior year.
• EBIT was -$2.8 million for Q2 2026 at VivoSim Labs, up from -$3.2 million in the prior quarter.
• The five-year high for EBIT was -$1.9 million in Q1 2022, with the low at -$7.8 million in Q1 2023.
• Average EBIT over 5 years is -$3.4 million, with a median of -$3.2 million recorded in 2022.
• The sharpest annual moves came in 2023 and 2024: EBIT sank 306.64% in 2023, then jumped 60.2% in 2024.
• Over 5 years, EBIT stood at -$3.4 million in 2022, then declined by 9.56% to -$3.7 million in 2023, then grew by 5.76% to -$3.5 million in 2024, then advanced by 20.7% to -$2.8 million in 2025, then retreated by 0.33% to -$2.8 million in 2026.
• The last three EBIT figures came in at -$2.8 million (Q2 2026), -$3.2 million (Q1 2026), and -$2.8 million (Q4 2025), per Business Quant data.